Study of NPL-2003 in Adolescents With Obsessive Compulsive Disorder (OCD)

Neuropharm

Status and phase

Terminated

Phase 2

Conditions

Obsessive Compulsive Disorder

Treatments

Drug: Minocycline

Study type

Interventional

Funder types

Industry

Identifiers

NCT00515255

NPL-2003-1-POCD-001

Details and patient eligibility

About

The purpose of this study is to investigate the effect of NPL-2003 on the symptoms of Obsessive Compulsive Disorder (OCD) in an adolescent population.

Enrollment

6 patients

Sex

All

Ages

12 to 17 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Meets DSM-IV criteria for Obsessive Compulsive Disorder.
CY-BOCS score of greater or equal to 16 at screening.
NIMH Global OC Scale score of 7 or higher at screening.

Exclusion criteria

Patients planning to commence cognitive behaviour therapy during the period of the study or those who have begun cognitive behaviour therapy within 8 weeks prior to enrolment.
Autistic Disorder or Pervasive Developmental Disorder.
Moderate or severe mental retardation.
Severe renal insufficiency.

Other protocol-defined Inclusion/Exclusion criteria may apply.